Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
The Lancet. Neurology|March 24, 2012
Association between pathological and MRI findings in multiple sclerosisMassimo Filippi, Maria A Rocca, Frederik Barkhof, et al.
Multiple Sclerosis and Related Disorders|January 21, 2021
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 yearsAnn D Bass, Rafael Arroyo, Aaron L Boster, et al.
BMC Neurology|November 15, 2013
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot studyTanuja Chitnis, Charles R Guttmann, Alexander Zaitsev, et al.
CNS Drugs|July 26, 2020
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension StudyTjalf Ziemssen, Ann D Bass, Regina Berkovich, et al.
Brain : a Journal of Neurology|June 5, 2014
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergeticsOscar G Vidaurre, Jeffery D Haines, Ilana Katz Sand, et al.
Genes and Immunity|March 20, 2026
Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patientsSara Benavides, Scott Christley, Kiel M Telesford, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 30, 2022
Toward Precision Phenotyping of Multiple SclerosisDavid Pitt, Chih Hung Lo, Susan A Gauthier, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 30, 2017
Radiologically isolated syndrome in children: Clinical and radiologic outcomesNaila Makhani, Christine Lebrun, Aksel Siva, et al.
Neurology|April 25, 2018
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Neurology|April 25, 2018
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAlexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, et al.
Pageof 18